Thanks, we’ve received your application.
Our team will review your application to see if your skills and experience are a good fit for the position – in the meantime, learn about the latest clinical evidence supporting the CathWorks FFRangio® System.
FFRangio Validation Study
The FFRangio Validation study evaluated 203 lesions in 184 patients and showed that there is high concordance between FFRangio and invasive FFR, including a diagnostic accuracy of 93%.
FAST-FFR Pivotal Trial
The FAST-FFR pivotal trial was a prospective multicenter, international trial designed to determine the accuracy of FFRangio in clinical practice compared to traditional wire-based FFR. The trial included 301 patients and 319 vessels at 10 clinical sites.
FFRangio in Dual/Triple Vessel Disease
This prospective clinical study conducted at Gifu Heart Centre, Japan—evaluated the diagnostic performance of FFRangio in 50 patients with dual or triple vessel CAD compared to wire-based FFR.
FFRangio Pooled Analysis from 5 Prospective Cohort Studies
This lesion-level pooled data analysis of 588 patients and 700 lesions represents the “largest and most diverse cohort of any single angiogram-based FFR technology reported.”